REQUEST A DEMO
Total
USD $0.00
Search more companies

Halic Pharma Anadolu Ecza Deposu A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Halic Pharma Anadolu Ecza Deposu Sanayi Ve Ticaret Anonim Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English Download a sample report

Halic Pharma Anadolu Ecza Deposu A.S. is an enterprise based in Turkiye. Its main office is in Istanbul. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on February 21, 2020. 12 (2025) employees currently work for Halic Pharma Anadolu Ecza Deposu A.S.. In its most recent financial highlights, the company reported a net sales revenue increase of 2135.27% in 2021. Its’ total assets recorded a growth of 515.7%. In, 2021, the company’s net profit margin increased by 72.42%.

Headquarters
No:76 Kosuyolu Mahallesi Katip Salih Sokak Kadikoy
Istanbul; Marmara; Postal Code: 34718

Contact Details: Purchase the Halic Pharma Anadolu Ecza Deposu A.S. report to view the information.

Website: http://www.pharmaist.com.tr

Basic Information
Total Employees:
Purchase the Halic Pharma Anadolu Ecza Deposu A.S. report to view the information.
Financial Auditors:
Purchase the Halic Pharma Anadolu Ecza Deposu A.S. report to view the information.
Incorporation Date:
February 21, 2020
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Halic Pharma Anadolu Ecza Deposu A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
2135.27%
Total operating revenue
2135.27%
Operating profit (EBIT)
-22.3%
Net Profit (Loss) for the Period
-98.22%
Total Assets
515.7%
Total Equity
-389.74%
Operating Profit Margin (ROS)
73.53%
Net Profit Margin
72.42%
Return on Equity (ROE)
-117.04%
Debt/Equity
20.04%
Quick Ratio
0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?